XML 25 R13.htm IDEA: XBRL DOCUMENT
v3.25.1

Capitalized Software Development Costs, Work in Progress | 12 Months Ended
--- | ---
Dec. 31, 2024
Capitalized Software Development Costs, Work in Progress [Abstract] |
Capitalized Software Development Costs, Work In Progress | Note 7 - Capitalized Software Development costs, work in progress As of December 31, 2024, the Company continues to assess the carrying amount of capitalized software for impairment, considering expected future benefits and cash flows to determine recoverability.
|  | December 31, 2024 |  |  | December 31, 2023 |
|  | Gross carrying amount |  |  | Additions |  |  | Impaired(1) |  |  | Reclassified to Intangibles & Expenses (2) |  |  | Net carrying value |  |  | Gross carrying amount |  |  | Additions |  |  | Net carrying value |
Capitalized Software Development costs, work in progress |  | $ | 839,085 |  |  | $ | 516,544 |  |  | $ | (202,968 | ) |  | $ | (1,046,761 | ) |  | $ | 105,900 |  |  | $ | 589,645 |  |  | $ | 249,440 |  |  | $ | 839,085 |
Total |  | $ | 839,085 |  |  | $ | 516,544 |  |  | $ | (202,968 | ) |  | $ | (1,046,761 | ) |  | $ | 105,900 |  |  | $ | 589,645 |  |  | $ | 249,440 |  |  | $ | 839,085 |
(1) | During year-end 2024, the Company performed an assessment of capitalized software for impairment. As a result, the Company impaired Work-in-Progress (“WIP”) related to reAlpha HUMINT and our technology for completing Syndications due to no further development and lack of use cases. The impaired amount was removed from the carrying value of WIP and recorded as an impairment expense in the financial statements.
(2) | On August 20, 2024, the Company reclassified a portion of WIP to intangible assets, specifically: $156,800 to GENA, $593,843 to the reAlpha platform and also reclassified the additions made to Claire post reclassification of $150,372. Both Claire and GENA began amortization over five years starting August 20, 2024, in accordance with ASC 350 and also includes reclassification of capitalized cost of $145,746 to expenses during the period ended December 31, 2024.

X
- References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/985-20/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1 + Details
Name: | us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration